KORU Medical Systems, Inc.

KRMD

US7599101026

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 01:00:00 2024-07-03 pm EDT			5-day change	1st Jan Change
2.54 ^USD	+11.89%		-11.19%	+3.46%

Jul. 02	Koru Medical Systems' FreedomEdge System Receives Regulatory Approval in Japan	MT
Jul. 02	KORU Medical Systems Receives Regulatory Clearance for FreedomEdge Infusion System in Japan	CI

KORU Medical Systems, Inc.(NasdaqCM:KRMD) dropped from Russell Small Cap Completeness Index

July 30, 2024

Latest news about KORU Medical Systems, Inc.

Koru Medical Systems' FreedomEdge System Receives Regulatory Approval in Japan	Jul. 02	MT
KORU Medical Systems Receives Regulatory Clearance for FreedomEdge Infusion System in Japan	Jul. 02	CI
KORU Medical Systems, Inc.(NasdaqCM:KRMD) dropped from Russell 2000 Dynamic Index	Jun. 30	CI
KORU Medical Systems, Inc.(NasdaqCM:KRMD) dropped from Russell Small Cap Comp Growth Index	Jun. 30	CI
KORU Medical Systems, Inc.(NasdaqCM:KRMD) dropped from Russell Small Cap Completeness Index	Jun. 30	CI
KORU Medical Systems, Inc.(NasdaqCM:KRMD) dropped from Russell 3000E Index	Jun. 30	CI
KORU Medical Systems, Inc.(NasdaqCM:KRMD) dropped from Russell 2500 Growth Index	Jun. 30	CI
SCHOTT Pharma and KORU Medical Systems Announce Collaboration to Advance Large Volume Subcutaneous Infusion	Jun. 05	CI
KORU Medical Systems, Inc. Announces Collaboration with Global Pharmaceutical Company to Initiate Feasibility Study with Its Freedom Infusion System for FDA and EMA Approved Subcutaneous Oncology Biologic Drug	Jun. 04	CI
KORU Medical Systems Signs Supply Agreement for a Phase III Clinical Trial for a Novel Endocrinological Biologic	May. 14	CI
Earnings Flash (KRMD) KORU MEDICAL SYSTEMS Posts Q1 Revenue $8.2M, vs. Street Est of $7.5M	May. 01	MT
Transcript : KORU Medical Systems, Inc., Q1 2024 Earnings Call, May 01, 2024	May. 01
KORU Medical Systems, Inc. reaffirms Financial Guidance for the Full Year of 2024	May. 01	CI
KORU Medical Systems, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 01	CI
Transcript : KORU Medical Systems, Inc., Q4 2023 Earnings Call, Mar 13, 2024	Mar. 13
KORU Medical Systems, Inc. Enters into Loan and Security Agreement with HSBC Ventures USA Inc	Mar. 13	CI
KORU Medical Systems, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 13	CI
KORU Medical Systems, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 13	CI
Earnings Flash (KRMD) KORU MEDICAL SYSTEMS Reports Q4 Revenue $7.2M, vs. Street Est of $6.9M	Mar. 13	MT
KORU Medical Systems, Inc. Provides Earnings Guidance for the Full Year 2024	Mar. 13	CI
KORU Medical Systems, Inc. Announces A Feasibility Study to Enter Ambulatory Infusion Settings with A Commercialized Biologic	Mar. 11	CI
KORU Medical Systems, Inc. Signs Clinical Supply Agreement for Phase 3 Trial with Leading Pharma Partner Using Custom Device for Novel Subcutaneous Immunoglobulin	Mar. 06	CI
Transcript : KORU Medical Systems, Inc. - Analyst/Investor Day	Dec. 05
Transcript : KORU Medical Systems, Inc., Q3 2023 Earnings Call, Nov 08, 2023	Nov. 08
Earnings Flash (KRMD) KORU MEDICAL SYSTEMS Posts Q3 Revenue $7M, vs. Street Est of $7.9M	Nov. 08	MT

Chart KORU Medical Systems, Inc.

Duration

Period

More charts

KORU Medical Systems, Inc. designs, manufactures, and markets proprietary portable and advanced medical devices primarily for the subcutaneous drug delivery market. The Company is focused on home and specialty infusion solutions. Its focus is primarily concentrated on its mechanical infusion products, the FREEDOM Infusion Systems, which include the FREEDOM60 Syringe Driver, the FreedomEdge Syringe Driver, HIgH-Flo Subcutaneous Safety Needle Sets, and Precision Flow Rate Tubing. The devices are used for infusions administered at home and in alternate care settings. Its infusion devices work together as a system to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD) and chronic inflammatory demyelinating polyneuropathy (CIDP). The FREEDOM System operates at a lower pressure than an electrical, volumetric pump and maintains a balance between what a patientâs subcutaneous tissues can tolerate and what the system delivers.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-08-05 - Q2 2024 Earnings Release (Projected)

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for KORU Medical Systems, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

2.54 USD

Average target price

3.5 USD

Spread / Average Target

+37.80%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
KORU MEDICAL SYSTEMS, INC.	+3.46%	116M
ABBOTT LABORATORIES	-7.03%	178B
MEDTRONIC PLC	-6.32%	98.95B
BECTON, DICKINSON AND COMPANY	-6.15%	66.14B
DEXCOM, INC.	-10.62%	44.11B
CENCORA, INC.	+8.34%	43.82B
HOYA CORPORATION	+12.17%	42.07B
METTLER-TOLEDO INTERNATIONAL, INC.	+11.64%	28.92B
TERUMO CORPORATION	+18.24%	24.69B
WEST PHARMACEUTICAL SERVICES, INC.	-8.87%	23.38B

Other Medical Equipment, Supplies & Distribution